Prediction Model for Familial Aggregated HBV ‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers
Cancer Reports · 2025
DOI: 10.1002/cnr2.70253 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Reports, 2025. Verfasst von Linmei Zhong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Postgraduate Training Base Alliance, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Biomarkers, Tumor, Hepatitis B. Die Arbeit nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Lanzhou Science and Technology Bureau, Gansu Province Health Industry Project.
Abstract (Originalsprache)
Background
Accurate assessment of the risk of familial aggregated hepatitis B virus (HBV)‐associated hepatocellular carcinoma (HCC) and regular surveillance for these patients at high risk may be valuable to reduce the occurrence and improve the prognosis of HCC.
Aim
This study aimed to develop a simple and reliable prediction model for the risk of HCC in these patients. Methods and Results This study analyzed clinical laboratory results from a database of 1285 patients with familial aggregated HBV who attended the First Hospital of Lanzhou University from January 2010 to December 2019. Univariate and multivariate logistic regression (LR) analysis showed that hemoglobin (Hb), neutrophil percentage (NP), total protein (TP), glutamyl transpeptidase (GGT), alglucosidase alfa (AFU), aspartate aminotransferase (AST) to Alanine aminotransferase (ALT) ratio (AAR), and alpha‐fetoprotein (AFP) were identified to be independent risk factors for HBV‐associated HCC. Prediction models were developed using a multivariate LR model, classification and regression tree, Native Bayes, Bagged tree, AdaBoost, and random forest. We used a multivariate LR model as a benchmark for performance assessment (AUC = 0.737). The results showed that the Native Bayes model had an AUC of 0.749, which was better than that of the other models.
Conclusion
Finally, the Native Bayes model demonstrated better predictive performance for HCC, which helped in the clinical decision‐making and identification of HCC high‐risk groups.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Postgraduate Training Base Alliance, Wenzhou Medical University, Wenzhou, Zhejiang, People's Republic of China.
- Department of Colorectal Hernia Surgery, Binzhou Medical University Hospital, Binzhou, Shandong, People's Republic of China.
- Department of Pediatrics, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China.
- The First School of Clinical Medicine, Lanzhou University, Lanzhou, Gansu, People's Republic of China.
- Department of General Surgery, The First Hospital of Lanzhou University, Lanzhou, Gansu, People's Republic of China.
- Key Laboratory of Biotherapy and Regenerative Medicine of Gansu Province, Lanzhou, Gansu, People's Republic of China.
ORCID-Profile: Linmei Zhong, Guole Nie, Qiaoping Wu, Honglong Zhang, Haiping Wang, Jun Yan
Förderung
- Lanzhou Science and Technology Bureau
- Gansu Province Health Industry Project
Zitieren
APA
Zhong, L., Nie, G., Wu, Q., Zhang, H., Wang, H., & Yan, J. (2025). Prediction Model for Familial Aggregated HBV ‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers. Cancer Reports. https://doi.org/10.1002/cnr2.70253
Vancouver
Zhong L, Nie G, Wu Q, Zhang H, Wang H, Yan J. Prediction Model for Familial Aggregated HBV ‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers. Cancer Reports. 2025. doi:10.1002/cnr2.70253
BibTeX
@article{Zhong2025,
author = {Zhong, Linmei and Nie, Guole and Wu, Qiaoping and Zhang, Honglong and Wang, Haiping and Yan, Jun},
title = {Prediction Model for Familial Aggregated HBV ‐Associated Hepatocellular Carcinoma Based on Serum Biomarkers},
journal = {Cancer Reports},
year = {2025},
doi = {10.1002/cnr2.70253}
}
EUVIMED